Cite this: Native Triple-Valve Endocarditis Caused by Penicillin-Resistant Streptococcus sanguis - Medscape - Jun 01, 2007. Summary and Case Discussion of Diagnosis ...

In EARLY TAVR, intervention improved outcomes over waiting in patients with class II or no indications for AVR consideration.

Patients received a new treatment for heart valve disease, which did not require riskier open-heart surgery or travel to London. Five people from Cambridgeshire, Essex, Hertfordshire, Peterborough and ...

The medtech startup is seeking funding for clinical trials to bring its catheter-based technique to more patients.